Clinical Trial Update: EGFR-targeted Therapy for Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update of an EGFR-targeted therapy in gastric cancer (adenocarcinoma of the stomach).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Stomach
• Gastric Cancer

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Adenocarcinoma of the Stomach | Phase 2 | Status: UNKNOWN